Filter
892
Filtered Results: 892
Text search:
World
Health
Organization
(Cambodia)
Featured
Recommendations
49
New Publications
228
Language
Document type
No document type
565
Studies & Reports
150
Guidelines
91
Manuals
28
Strategic & Response Plan
16
Fact sheets
12
Resource Platforms
9
Situation Updates
8
Infographics
7
Training Material
5
Brochures
1
Countries / Regions
Cambodia
86
Global
65
Myanmar / Burma
36
Asia
33
Kenya
17
South–East Asia Region
15
Vietnam
14
Nepal
13
Philippines
13
Ethiopia
12
Laos
11
India
11
Thailand
9
Rwanda
8
Indonesia
8
Western Pacific Region
7
Bangladesh
7
South Africa
7
China
6
Senegal
6
Tanzania
6
Liberia
6
Sierra Leone
5
Africa
5
Russia
5
Ukraine
4
Ghana
4
Cameroon
4
Nigeria
4
Malawi
4
Latin America and the Carribbean
4
Benin
3
Mozambique
3
Western and Central Europe
3
Namibia
3
Zambia
3
Pakistan
3
Syria
2
Burkina Faso
2
Malaysia
2
Guinea
2
West and Central Africa
2
Uganda
2
Eastern Europe
2
Yemen
2
South Sudan
2
Switzerland
1
Colombia
1
Mexico
1
Lesotho
1
Singapore
1
Kyrgyzstan
1
Afghanistan
1
Zimbabwe
1
USA
1
Haiti
1
Jordan
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Turkmenistan
1
Japan
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Brazil
1
Sri Lanka
1
Egypt
1
Palestine
1
Honduras
1
Chad
1
Ecuador
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
219
Clinical Guidelines
67
Public Health
62
Key Resources
59
Women & Child Health
52
Capacity Building
18
Pharmacy & Technologies
13
Toolboxes
HIV
128
Disability
79
Mental Health
70
TB
70
NTDs
35
Planetary Health
33
COVID-19
31
Malaria
29
AMR
21
Global Health Education
20
Rapid Response
14
Caregiver
14
Pharmacy
14
Health Financing Toolbox
13
NCDs
11
Conflict
10
Natural Hazards
7
Ebola & Marburg
7
Specific Hazards
6
Refugee
6
2.0 Rapid Response
5
Zika
4
Polio
4
Typhoon
1
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
Guidelines
Key Populations
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Q3: What approaches are available to enable non-specialized health care providers to identify children with intellectual disabilities, including intellectual disabilities due to specific causes?
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e...
Guidelines
HIV testing services
July 2015
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.
The document provides guidance on the tools, activities and strategies required to achieve malaria elimination and prevent re-establishment of transmission in countries, regardless of where they lie across the spectrum of transmission intensity. It is intended to inform national malaria elimination ...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
TECHNICAL NOTE III
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2017
Weekly epidemiological record 18 July 2025
This report summarizes application of the SAFE strategy against trachoma during 2024. It includes estimates of the global population at risk of trachoma blindness based on district-by-district data submitted to WHO by national programmes.
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
Putting Asia’s HIV response back on track
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
(updated December 2014).
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with...
